Dow Up0.42% Nasdaq Up0.10%

Techne Corp. (TECH)

95.47 Down 0.78(0.81%) 3:21PM EDT - Nasdaq Real Time Price
ProfileGet Profile for:
Techne Corp.
614 McKinley Place North East
Minneapolis, MN 55413-2610
United States - Map
Phone: 612-379-8854
Fax: 612-379-6580

Index Membership:N/A
Full Time Employees:1,000

Business Summary 

Techne Corporation develops, manufactures, and sells biotechnology products and clinical diagnostic controls worldwide. It operates in two segments, Biotechnology and Clinical Controls. The company’s Biotechnology segment provides proteins, such as cytokines, and enzyme substrates and inhibitors; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits for the detection of human and animal proteins, and immunoassays that allow researchers to quantify a specific analyte in a biological fluids sample; and clinical diagnostic immunoassay kits consisting of erythropoietin, transferrin receptor, and beta2-microglobulin immunoassays for use as in vitro diagnostic devices. This segment also offers flow cytometry products, such as fluorochrome labeled antibodies and kits; intracellular cell signaling products, including antibodies, phospho-specific antibodies, antibody arrays, active caspases, kinases, phosphatases, and enzyme-linked immunosorbant assays to measure the activity of apoptotic and signaling molecules; and natural and synthetic chemical compounds for use as agonists, antagonists, and inhibitors of various biological functions by investigators. Its Clinical Controls segment provides a range of hematology controls and calibrators for impedance and laser type cell counters; and hematology control products for use as proficiency testing tools by laboratory certifying authorities. The company was founded in 1976 and is headquartered in Minneapolis, Minnesota.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Techne Corp.

Corporate Governance 
Techne Corp.’s ISS Governance QuickScore as of Aug 1, 2014 is 5. The pillar scores are Audit: 5; Board: 9; Shareholder Rights: 1; Compensation: 9.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
Mr. Charles R. Kummeth , 54
Chief Exec. Officer, Pres and Director
Dr. Roger C. Lucas Ph.D., 71
Vice Chairman, Sr. Scientific Advisor, Member of Nominations & Governance Committee and Member of Scientific Subcommittee
Mr. Marcel Veronneau , 60
Sr. VP of Clinical Controls
Mr. James T. Hippel ,
Chief Financial Officer
Kathleen M. Backes ,
Chief Accounting Officer and Controller
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders